Results 111 to 120 of about 17,995 (248)

Regular Medications Administered to Older Adults in Aged Care Facilities: A Retrospective Descriptive Study

Journal of Clinical Nursing, Volume 35, Issue 1, Page 363-374, January 2026.
ABSTRACT Aim(s) To explore which regularly prescribed medications are most commonly administered to older adults in aged care facilities in Australia, by whom and when, and to identify the prevalence of polypharmacy in this population group. Design Retrospective descriptive study.
Stephanie M. Garratt, Maneesh Prasad, Kelly Ottosen, Elizabeth Manias   +3 more
wiley   +1 more source

Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa [PDF]

, 2017
Aravind Mittur, Suneel Gupta, Nishit B. Modi   +2 more
openalex   +1 more source

Targeting the Sirtuin–1/PPAR–Gamma Axis, RAGE/HMGB1/NF-κB Signaling, and the Mitochondrial Functions by Canagliflozin Augments the Protective Effects of Levodopa/Carbidopa in Rotenone-Induced Parkinson’s Disease

Medicina
Background and Objectives: Parkinson’s disease (PD) is a pathological state characterized by a combined set of abnormal movements including slow motion, resting tremors, profound stiffness of skeletal muscles, or obvious abnormalities in posture and gait,
Mennatallah A. Elkady, Ahmed M. Kabel, Lamees M. Dawood, Azza I. Helal, Hany M. Borg, Hanan Abdelmawgoud Atia, Nesreen M. Sabry, Nouran M. Moustafa, El-Shaimaa A. Arafa, Shuruq E. Alsufyani, Hany H. Arab   +10 more
doaj   +1 more source

Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC‐HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel

Pharmacology Research & Perspectives
Analysis was conducted to compare levodopa/carbidopa pharmacokinetics and drug‐related material in plasma of healthy participants after receiving a continuous infusion of Levodopa/Carbidopa Intestinal Gel (LCIG) to a continuous subcutaneous infusion of ...
John P. Savaryn, Richard L. Smith, Matthew Rosebraugh, Melina Neenan, Richard Burton, Kennan Marsh, David Wagner   +6 more
doaj   +1 more source

Neuro- és citoprotektív mechanizmusok kutatása. = Studies on neuro- and cytoprotective mechanisms. [PDF]

, 2007
Az elmúlt négy évtized magyar gyógyszerkutatásának sikervegyületét, a (-)-deprenylt tanulmányoztuk a neuroprotektív hatás újabb lehetőségeinek feltárására. Vizsgáltuk a deprenyl-N-oxid képződését és farmakokinetikáját.
Halász, Attila Sándor, Knippel, Barbara, Lengyel, József, Magyar, Kálmán, Szarkáné Bolehovszky, Andrea, Szökő, Éva, Tekes, Kornélia, Tábi, Tamás, Tóthfalusi, László, Török, Tamás   +9 more
core  

Switching Gears: From Intrajejunal Levodopa to Subcutaneous Foslevodopa

Movement Disorders Clinical Practice, Volume 13, Issue 1, Page 291-293, January 2026.
Walaa B. Mohammed, Alexandra McGuckin, Yu‐Yan Poon, Alfonso Fasano   +3 more
wiley   +1 more source

Von Economo’s disease and postencephalitic parkinsonism responsive to carbidopa and levodopa

Neuropsychiatric Disease and Treatment, 2018
Daniel Y Bigman, Bradford D Bobrin Department of Psychiatry, Cooper University Hospital, Cooper Medical School of Rowan University, Camden, NJ, USA Abstract: Postencephalitic parkinsonism (PEP) is currently perceived as having a very close etiologic ...
Bigman DY, Bobrin BD
doaj  

Characterization of Vitamin B12 Supplementation and Correlation with Clinical Outcomes in a Large Longitudinal Study of Early Parkinson's Disease. [PDF]

, 2019
ObjectiveIn Parkinson's disease (PD), vitamin B12 levels are lower, and comorbid B12 deficiency has been associated with the development of neuropathy and early gait instability.
Christine, Chadwick W, Dietiker, Cameron, Kim, Soeun, Zhang, Yunxi   +3 more
core  

Increasing the solubility of levodopa and carbidopa using ionization approach

, 2020
Kitisak Krisai, Dusadee Charnvanich, Wanchai Chongcharoen   +2 more
openalex   +2 more sources

Treatment of Early Parkinson's Disease [PDF]

, 2005
Treatment of early Parkinson's disease with either selegiline (Eldepryl), a dopamine agonist (pramipexole [Mirapex], ropinirole [Requip], or bromocriptine [Parlodel]), or the combination of levodopa and carbidopa (Sinemet) or levodopa and cabidopa with ...
Dickerson, Lori M., Nashelsky, Joan, Simpson, William M., Young, Sara E.   +3 more
core